Cal Baier-Anderson, Ph.D., is a Health Scientist.
We often think of nanotechnology as the latest product of ultra-modern science, but humans did not invent the nanoscale. We were not even the first to use materials with nanoscale features: The gecko beat us to it by several million years. Even more impressive, this little reptile has managed to use nanoscale materials apparently without experiencing any ill effects. It remains to be seen if we will be able to do this.
Read More
John Balbus, M.D., M.P.H., is Chief Health Scientist.
The history of health and environmental impacts of fuel additives is not a pretty one. From tetra-ethyl lead to methyl tert-butyl ether (MTBE), we’ve learned the hard way that what goes in the tank ends up in our bodies and the environment sooner or later. Getting a thorough understanding of the potential risks of a new fuel additive at an early stage is essential to avoid a lot of harm, suffering, and economic costs down the line.
A new study by Park et al. has assessed the potential respiratory risks of a fuel additive called Envirox (nanoparticulate cerium oxide), giving it a clean bill of health based only on in vitro tests. Is this the vision of the future of risk assessment? Should we feel safe? Read More
Cal Baier-Anderson, Ph.D., is a Health Scientist.
With conventional chemicals, experience has allowed us to articulate general criteria based on chemical properties that identify chemicals of greatest concern. For example, persistent and bioaccumulative chemicals are assigned a high priority, whereas chemicals that quickly degrade and don’t build up in blood or tissue are, as a rule, likely to be of lower priority.
Concerns about nanomaterials arise from observations that properties that emerge or are greatly enhanced at the nanoscale can alter behavior, including biological activity. These properties make such materials different from conventional forms of the same chemicals. But can a general principle that nanomaterials pose a greater concern than their conventional counterparts be supported? Read More
Scott Walsh, MBA, is a Project Manager.
As we’ve noted in this blog and elsewhere, there’s a ton of uncertainty out there about what potential risks may arise from the production, use and disposal of engineered nanomaterials. And unfortunately for companies trying to work with such materials (and the rest of us who may be exposed to them), there’s still not much guidance on how to identify, manage and mitigate potential risks.
On April 2nd and April 8th, Terry Medley and Keith Swain from DuPont and I will be leading two interactive workshops on nano risk management. Read More
Richard Denison, PhD, is a Senior Scientist.
Just after publishing my last post, I learned that the European Commission’s Scientific Committee on Consumer Products has released a new Scientific Opinion that concludes current risk assessment procedures and methods applied to cosmetics, in particular sunscreens, are insufficient. Read More
Cal Baier-Anderson, PhD, is a Health Scientist.
In the current regulatory environment, where there are no regulations that specifically take into account the unique properties of engineered nanomaterials, industry has by default the primary responsibility for their safe production and use. Is industry taking this responsibility seriously?
Two recent studies, one in Europe and one in the U.S., shed light on this question and reveal some reasons to be concerned. Read More
